G1 Therapeutics (NASDAQ:GTHX) reported its Q1 earnings results on Wednesday, May 4, 2022 at 06:30 AM.
Here's what investors need to know about the announcement.
Earnings
G1 Therapeutics missed estimated earnings by 18.56%, reporting an EPS of $-1.15 versus an estimate of $-0.97.
Revenue was down $7.32 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.09 which was followed by a 12.3% increase in the share price the next day.
Here's a look at G1 Therapeutics's past performance:
| Quarter | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|
| EPS Estimate | -1.03 | -1 | -0.97 | -1.07 |
| EPS Actual | -0.94 | -1 | -0.94 | -0.65 |
| Revenue Estimate | 5.68M | 5.18M | 2.59M | 770.00K |
| Revenue Actual | 5.80M | 4.86M | 6.60M | 14.22M |
To track all earnings releases for G1 Therapeutics visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
